-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
MiNK Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2020 to 2023.
- MiNK Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $844K, a 6.01% decline year-over-year.
- MiNK Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $3.58M, a 9.85% increase year-over-year.
- MiNK Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $3.83M, a 26.5% increase from 2022.
- MiNK Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $3.03M, a 73.5% increase from 2021.
- MiNK Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $1.75M, a 1883% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)